Stroke Diagnostics and Therapeutics Industry
Description
The Global Stroke Diagnostics and Therapeutics Market is valued at $20.5 billion in 2014 and it is expected to reach nearly $34.4 billion by 2022, growing at a CAGR of 6.68% from 2014 to 2022. Stroke is referred to brain attack, this occurs when there is an interruption in the supply of blood to the brain which leads brain cells to die. The factors driving the Global Stroke Diagnostics and Therapeutics Market include technological advancement, growing aging population, and people suffering from diabetes, increasing health expenditure, hypertension and also increasing tobacco users. However factors such as unfavourable reimbursement scenario and high cost of treatments are restraining the market growth.
The Global Stroke Diagnostics and Therapeutics Market is categorized by type, application and geography. By type, the market is segmented into Diagnostics and Therapeutics. The Diagnostics is sub categorized into Magnetic Resonance Imaging (MRI), Computed Tomography Scan (CT scan), Electrocardiography, Carotid Ultrasound, Cerebral Angiography and Others. The Therapeutics is sub segmented into Tissue Plasminogen Activator, Antiplatelet, Antihypertensive and Anticoagulant. On the basis of application, the Stroke Diagnostics and Therapeutics Market is segmented into haemorrhagic stroke and ischemic stroke. Ischemic strokes are caused due to blocked or narrowed arteries that connect to the brain, which results in reduced blood flow in these arteries.
Hemorrhagic stroke is caused on account of the arteries in the brain either leaking blood or bursting open. In the TIAs, the flow of blood to the brain is only disrupted temporarily for a short period of time. By geography, it is segmented into North America, Europe, Asia Pacific, and Rest of the World. North America has the largest market for stroke diagnostics and therapeutics followed by Europe. This is due to the increasing number of patients at the risk of developing stroke, technologically advanced equipment for the diagnosis and treatment of stroke, rise in research and development activities, increasing awareness among people about the causes of stroke, and improved healthcare infrastructure in the region.
The stroke diagnostics and therapeutics market in Asia is expected to witness the high growth rate in the next few years. This is due to growing aging population, evolving R&D activities for drug discovery and development, increasing government support in the form of funding, growing awareness about stroke and its causes, and developing healthcare infrastructure in the region. In addition, growing demographics and economies in the developing countries such as India, China, and Japan are expected to lead the growth in the stroke diagnostics and therapeutics market in Asia.
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/4590811-stroke-diagnostics-and-therapeutics-global-market-outlook-trends
Some of the prominent players in Global Stroke Diagnostics and Therapeutics Market include Abbott Laboratories, Siemens AG, Stryker Corporation, GE Healthcare, Medtronic plc, Cordis Corporation, Genentech Inc., Boston Scientific Corporation, Coaxia Inc. and Philips Healthcare.
Segmental Analysis
The report on the global Stroke Diagnostics and Therapeutics market divides the market into different region-based segments according to the regions that each one is located in. The major regions that are covered in the market report include North America, South America, Asia-Pacific, the Middle East, Europe, and Africa. The market share of Stroke Diagnostics and Therapeutics in these regions is calculated and is presented in the report. This data is collected according to a variety of different parameters that are chosen to present the most accurate data and the status of the different regions. The report includes the data for the review year 2019 to 2025 and the data is forecast from the year 2019 to 2025. The Stroke Diagnostics and Therapeutics market report also segments the market based on products/services and end-user/applications.
What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 8 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements
Leave a Query @ https://www.wiseguyreports.com/enquiry/4590811-stroke-diagnostics-and-therapeutics-global-market-outlook-trends
Table of Content
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Research Scope
2.3 Research Methodology
2.4 Research Sources
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
4 Porters Five Force Analysis
5 Global Stroke Diagnostics and Therapeutics Market, By Type
6 Global Stroke Diagnostics and Therapeutics Market, By Application
7 Global Stroke Diagnostics and Therapeutics Market, By Geography
8 Key Developments
9 Company Profiling
9.1 Abbott Laboratories
9.2 Siemens AG
9.3 Stryker Corporation
9.4 GE Healthcare
9.5 Medtronic plc
9.6 Cordis Corporation
9.7 Genentech Inc.
9.8 Boston Scientific Corporation
9.9 Coaxia Inc
9.10 Philips Healthcare
Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=4590811
Continued…
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)
